|
1
|
Babashah S and Soleimani M: The oncogenic
and tumour suppressive roles of microRNAs in cancer and apoptosis.
Eur J Cancer. 47:1127–1137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lacko M, Braakhuis BJ, Sturgis EM, et al:
Genetic susceptibility to head and neck squamous cell carcinoma.
Int J Radiat Oncol Biol Phys. 89:38–48. 2014. View Article : Google Scholar
|
|
4
|
Kaumaya PT and Foy KC: Peptide vaccines
and targeting HER and VEGF proteins may offer a potentially new
paradigm in cancer immunotherapy. Future Oncol. 8:961–987. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vincenti V, Cassano C, Rocchi M and
Persico G: Assignment of the vascular endothelial growth factor
gene to human chromosome 6p21.3. Circulation. 93:1493–1495. 1996.
View Article : Google Scholar
|
|
6
|
Yang Y, Zhang X, Song D and Wei J:
Association between vascular endothelial growth factor gene
polymorphisms and bladder cancer risk. Mol Clin Oncol. 2:501–505.
2014.PubMed/NCBI
|
|
7
|
Ajaz S, Khaliq S, Abid A, et al:
Association of a single-nucleotide polymorphism in the promoter
region of the VEGF gene with the risk of renal cell carcinoma.
Genet Test Mol Biomarkers. 15:653–657. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Antonacopoulou AG, Kottorou AE,
Dimitrakopoulos FI, et al: VEGF polymorphisms may be associated
with susceptibility to colorectal cancer: a case-control study.
Cancer Biomark. 10:213–217. 2011.PubMed/NCBI
|
|
9
|
Dassoulas K, Gazouli M, Rizos S, et al:
Common polymorphisms in the vascular endothelial growth factor gene
and colorectal cancer development, prognosis, and survival. Mol
Carcinog. 48:563–569. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Deng ZC, Cao C, Yu YM, Ma HY and Ye M:
Vascular endothelial growth factor -634G/C and vascular endothelial
growth factor -2578C/A polymorphisms and lung cancer risk: a
case-control study and meta-analysis. Tumour Biol. 35:1805–1811.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Diao LP, Yu XM, Gao YH, et al: Association
of VEGF genetic polymorphisms with the clinical characteristics of
non-Hodgkin’s lymphoma. J Cancer Res Clin Oncol. 135:1473–1481.
2009.PubMed/NCBI
|
|
12
|
Galimberti S, Nagy B, Palumbo GA, et al:
Vascular endothelial growth factor polymorphisms in mantle cell
lymphoma. Acta Haematol. 123:91–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Henríquez-Hernández LA, Navarro P, Luzardo
OP, et al: Polymorphisms of glutathione S-transferase μ and θ, MDR1
and VEGF genes as risk factors of bladder cancer: a case-control
study. Urol Oncol. 30:660–665. 2012.
|
|
14
|
Hofmann G, Langsenlehner U, Renner W, et
al: Common single nucleotide polymorphisms in the vascular
endothelial growth factor gene and colorectal cancer risk. J Cancer
Res Clin Oncol. 134:591–595. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Howell WM, Bateman AC, Turner SJ, Collins
A and Theaker JM: Influence of vascular endothelial growth factor
single nucleotide polymorphisms on tumour development in cutaneous
malignant melanoma. Genes Immun. 3:229–232. 2002. View Article : Google Scholar
|
|
16
|
Hsiao PJ, Lu MY, Chiang FY, Shin SJ, Tai
YD and Juo SH: Vascular endothelial growth factor gene
polymorphisms in thyroid cancer. J Endocrinol. 195:265–270. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ianni M, Porcellini E, Carbone I, et al:
Genetic factors regulating inflammation and DNA methylation
associated with prostate cancer. Prostate Cancer Prostatic Dis.
16:56–61. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jacobs EJ, Feigelson HS, Bain EB, et al:
Polymorphisms in the vascular endothelial growth factor gene and
breast cancer in the Cancer Prevention Study II cohort. Breast
Cancer Res. 8:R222006. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jaiswal PK, Tripathi N, Shukla A and
Mittal RD: Association of single nucleotide polymorphisms in
vascular endothelial growth factor gene with bladder cancer risk.
Med Oncol. 30:5092013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jang MJ, Jeon YJ, Kim JW, et al:
Association of VEGF and KDR single nucleotide polymorphisms with
colorectal cancer susceptibility in Koreans. Mol Carcinog. 52(Suppl
1): E60–E69. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin Q, Hemminki K, Enquist K, et al:
Vascular endothelial growth factor polymorphisms in relation to
breast cancer development and prognosis. Clin Cancer Res.
11:3647–3653. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kämmerer PW, Koch FP, Schiegnitz E, et al:
Associations between single-nucleotide polymorphisms of the VEGF
gene and long-term prognosis of oral squamous cell carcinoma. J
Oral Pathol Med. 42:374–381. 2013.
|
|
23
|
Ke Q, Liang J, Wang LN, et al: Potentially
functional polymorphisms of the vascular endothelial growth factor
gene and risk of gastric cancer. Mol Carcinog. 47:647–651. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim YH, Kim MA, Park IA, et al: VEGF
polymorphisms in early cervical cancer susceptibility,
angiogenesis, and survival. Gynecol Oncol. 119:232–236. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Liang J, Liu X, et al: Correlation
of polymorphisms of the vascular endothelial growth factor gene and
the risk of lung cancer in an ethnic Han group of North China. Exp
Ther Med. 3:673–676. 2012.PubMed/NCBI
|
|
26
|
Li Y, Wang Y, Kang S, et al: Association
of vascular endothelial growth factor gene polymorphisms with
susceptibility to epithelial ovarian cancer. Int J Gynecol Cancer.
20:717–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang J, Yu X, Liu X, et al: Vascular
endothelial growth factor polymorphisms and risk of lung cancer.
Chin Ger J Clin Oncol. 8:269–272. 2009. View Article : Google Scholar
|
|
28
|
Maltese P, Canestrari E, Ruzzo A, et al:
VEGF gene polymorphisms and susceptibility to colorectal cancer
disease in Italian population. Int J Colorectal Dis. 24:165–170.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martinez-Fierro ML, Garza-Veloz I,
Rojas-Martinez A, et al: Positive association between vascular
endothelial growth factor (VEGF) -2578 C/A variant and prostate
cancer. Cancer Biomark. 13:235–241. 2013.PubMed/NCBI
|
|
30
|
Mishra K, Behari A, Kapoor VK, Khan MS,
Prakash S and Agrawal S: Vascular endothelial growth factor
single-nucleotide polymorphism in gallbladder cancer. J
Gastroenterol Hepatol. 28:1678–1685. 2013.PubMed/NCBI
|
|
31
|
Nasr HB, Chahed K, Bouaouina N and
Chouchane L: Functional vascular endothelial growth factor -2578
C/A polymorphism in relation to nasopharyngeal carcinoma risk and
tumor progression. Clin Chim Acta. 395:124–129. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nikiteas NI, Tzanakis N, Theodoropoulos G,
et al: Vascular endothelial growth factor and endoglin (CD-105) in
gastric cancer. Gastric Cancer. 10:12–17. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Park HM, Hong SH, Kim JW, et al:
Gender-specific association of the VEGF -2578C > A polymorphism
in Korean patients with colon cancer. Anticancer Res. 27:2535–2539.
2007.PubMed/NCBI
|
|
34
|
Pharoah PD, Tyrer J, Dunning AM, Easton DF
and Ponder BA: SEARCH Investigators: Association between common
variation in 120 candidate genes and breast cancer risk. PLoS
Genet. 3:e422005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sáenz-López P, Vazquez F, Cozar JM,
Carretero R, Garrido F and Ruiz-Cabello F: VEGF polymorphisms are
not associated with an increased risk of developing renal cell
carcinoma in Spanish population. Hum Immunol. 74:98–103. 2013.
|
|
36
|
Supic G, Jovic N, Zeljic K, Kozomara R and
Magic Z: Association of VEGF-A genetic polymorphisms with cancer
risk and survival in advanced-stage oral squamous cell carcinoma
patients. Oral Oncol. 48:1171–1177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
VanCleave TT, Moore JH, Benford ML, et al:
Interaction among variant vascular endothelial growth factor (VEGF)
and its receptor in relation to prostate cancer risk. Prostate.
70:341–352. 2010.PubMed/NCBI
|
|
38
|
Wang K, Liu L, Zhu ZM, Shao JH and Xin L:
Five polymorphisms of vascular endothelial growth factor (VEGF) and
risk of breast cancer: a meta-analysis involving 16,703
individuals. Cytokine. 56:167–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu LM, Xie HY, Zhou L, Yang Z, Zhang F and
Zheng SS: A single nucleotide polymorphism in the vascular
endothelial growth factor gene is associated with recurrence of
hepatocellular carcinoma after transplantation. Arch Med Res.
40:565–570. 2009. View Article : Google Scholar
|
|
40
|
Zhang L, Zhang G, Wang P, Gong J, Cao Y
and Tang L: Association of vascular endothelial growth factor
-2578C/A gene polymorphism in Chinese patients with colon cancer.
Genet Test Mol Biomarkers. 15:117–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim EJ, Jeong P, Quan C, et al: Genotypes
of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants
for clinical outcome of bladder cancer. Urology. 65:70–75. 2005.
View Article : Google Scholar : PubMed/NCBI
|
